Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shili Lin

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Nature Communications|April 5, 2019
Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistanceYufan Zhou, Diana L Gerrard, Junbai Wang, et al.
Bioinformatics (Oxford, England)|September 3, 2014
PrEMeR-CG: inferring nucleotide level DNA methylation values from MethylCap-seq dataDavid E Frankhouser, Mark Murphy, James S Blachly, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2020
The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure, and Glycemia in African AmericansJoshua J Joseph, Xiaofei Zhou, Mihail Zilbermint, et al.
Nature Communications|April 22, 2020
Author Correction: Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistanceYufan Zhou, Diana L Gerrard, Junbai Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
CD24 is a genetic modifier for risk and progression of multiple sclerosisQunmin Zhou, Kottil Rammohan, Shili Lin, et al.
Molecular Cancer Therapeutics|January 12, 2008
MicroRNAs modulate the chemosensitivity of tumor cellsPaul E Blower, Ji-Hyun Chung, Joseph S Verducci, et al.
Molecular Cancer Therapeutics|May 8, 2007
MicroRNA expression profiles for the NCI-60 cancer cell panelPaul E Blower, Joseph S Verducci, Shili Lin, et al.
JACC. Heart Failure|May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and MortalityCharles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
Cancer Research|December 17, 2008
Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cellsHuey-Jen L Lin, Tao Zuo, Ching-Hung Lin, et al.
Scientific Reports|December 2, 2023
Methane prediction equations including genera of rumen bacteria as predictor variables improve prediction accuracyBoyang Zhang, Shili Lin, Luis Moraes, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Nature Communications|April 5, 2019
Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistanceYufan Zhou, Diana L Gerrard, Junbai Wang, et al.
Bioinformatics (Oxford, England)|September 3, 2014
PrEMeR-CG: inferring nucleotide level DNA methylation values from MethylCap-seq dataDavid E Frankhouser, Mark Murphy, James S Blachly, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2020
The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure, and Glycemia in African AmericansJoshua J Joseph, Xiaofei Zhou, Mihail Zilbermint, et al.
Nature Communications|April 22, 2020
Author Correction: Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistanceYufan Zhou, Diana L Gerrard, Junbai Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
CD24 is a genetic modifier for risk and progression of multiple sclerosisQunmin Zhou, Kottil Rammohan, Shili Lin, et al.
Molecular Cancer Therapeutics|January 12, 2008
MicroRNAs modulate the chemosensitivity of tumor cellsPaul E Blower, Ji-Hyun Chung, Joseph S Verducci, et al.
Molecular Cancer Therapeutics|May 8, 2007
MicroRNA expression profiles for the NCI-60 cancer cell panelPaul E Blower, Joseph S Verducci, Shili Lin, et al.
JACC. Heart Failure|May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and MortalityCharles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
Cancer Research|December 17, 2008
Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cellsHuey-Jen L Lin, Tao Zuo, Ching-Hung Lin, et al.
Scientific Reports|December 2, 2023
Methane prediction equations including genera of rumen bacteria as predictor variables improve prediction accuracyBoyang Zhang, Shili Lin, Luis Moraes, et al.
Pageof 15